PFD overexpression has been observed in many tumor types, including pancreatic cancer and neuroblastoma [36], [37], whereas CCT overexpression has been observed in liver cancer and in the late stages of colon cancer [38], [39]. This evidence concerns the gene FLVCR2 and neuroblastoma.